SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-323187
Filing Date
2017-10-27
Accepted
2017-10-27 17:27:47
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d438110ds3.htm S-3 174425
2 EX-4.4 d438110dex44.htm EX-4.4 321566
3 EX-5.1 d438110dex51.htm EX-5.1 28297
4 EX-23.1 d438110dex231.htm EX-23.1 2849
5 GRAPHIC g438110g10t39.jpg GRAPHIC 44755
6 GRAPHIC g438110g39c41.jpg GRAPHIC 2836
7 GRAPHIC g438110g57z99.jpg GRAPHIC 5638
8 GRAPHIC g438110g89i39.jpg GRAPHIC 3912
9 GRAPHIC g438110g96n10.jpg GRAPHIC 1077
  Complete submission text file 0001193125-17-323187.txt   609041
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221198 | Film No.: 171160293
SIC: 2836 Biological Products, (No Diagnostic Substances)